Saturday, September 21, 2024

CATEGORY

NYSE Updates

MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints By Investing.com

Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM™ Subcutaneous Implantable Defibrillator and EMPOWER™ Leadless PacemakerMARLBOROUGH, Mass., May 18, 2024...

How to immunize your bond ETF if interest rates turn higher

Tips to hedge a portfolio against interest rate fluctuations.

Faraday Future Announces Fourth Quarter and Full Year 2023 Earnings Webcast Timing By Investing.com

LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) (Faraday Future, FF, or the Company), a California-based global shared intelligent electric mobility...

Riding the Roaring Kitty roller coaster: Why GameStop and AMC meme madness is an ‘outlier event’

“It felt as though the market briefly took a trip back to 2021 this week” — but the spike in GameStop and AMC...

Bank Midwest names new president Charlie Koch By Investing.com

KANSAS CITY - Bank Midwest, a division of NBH Bank, has announced the appointment of Charlie Koch as its new President, set to...

Landsec sees value of property portfolio drop but says return-to-office will boost its business

Higher interest rates knocked £625 million off the value of Landsec’s office portfolio

Fabricio Bloisi Appointed CEO, Prosus and Naspers By Investing.com

AMSTERDAM, Netherlands--(BUSINESS WIRE)--Prosus (OTC:) N.V. (AEX: PRX) today announced that the Boards of Prosus and Naspers have unanimously approved the appointment of...

‘Grand Theft Auto VI’ won’t come until fall 2025, and Take-Two shares slip

Shares of videogame maker Take-Two-Interactive Software Inc. fell 2% in after-hours trading Thursday after the company said its highly anticipated “Grate Theft Auto...

CFRA maintains buy rating and stock price target on Dillard’s stock By Investing.com

On Thursday, CFRA reiterated its Buy rating on Dillard's Inc. (NYSE:) with a steadfast stock price target of $500.00, reflecting confidence in the...

Roche ramps up obesity-drug competition with early-stage trial results

The race to develop powerful new weight-loss drugs grew even more heated on Thursday as Roche Holding released early-stage trial results for an...

Latest news